Low-dose dengue virus 3 human challenge model: a phase 1 open-label study

Bhatt, S. et al. The global distribution and burden of dengue. Nature 496, 504–507 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shepard, D. S., Coudeville, L., Halasa, Y. A., Zambrano, B. & Dayan, G. H. Economic impact of dengue illness in the Americas. Am. J. Trop. Med. Hyg. 84, 200–207 (2011).

Article  PubMed  PubMed Central  Google Scholar 

Guzman, M. G., Gubler, D. J., Izquierdo, A., Martinez, E. & Halstead, S. B. Dengue infection. Nat. Rev. Dis. Primers 2, 16055 (2016).

Article  PubMed  Google Scholar 

Gubler, D. J. Aedes aegypti and Aedes aegypti-borne disease control in the 1990s: top down or bottom up. Charles Franklin Craig lecture. Am. J. Trop. Med. Hyg. 40, 571–578 (1989).

Article  CAS  PubMed  Google Scholar 

Iwamura, T., Guzman-Holst, A. & Murray, K. A. Accelerating invasion potential of disease vector Aedes aegypti under climate change. Nat. Commun. 11, 2130 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Facts sheet Dengue. World Mosquito Program https://www.worldmosquitoprogram.org/sites/default/files/2020-11/WMP%20dengue_0.pdf (2022).

Anderson, K. B. et al. A shorter time interval between first and second dengue infections is associated with protection from clinical illness in a school-based cohort in Thailand. J. Infect. Dis. 209, 360–368 (2014).

Article  CAS  PubMed  Google Scholar 

Montoya, M. et al. Symptomatic versus inapparent outcome in repeat dengue virus infections is influenced by the time interval between infections and study year. PLoS Negl. Trop. Dis. 7, e2357 (2013).

Article  PubMed  PubMed Central  Google Scholar 

Guzman, M. G., Alvarez, M. & Halstead, S. B. Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection. Arch. Virol. 158, 1445–1459 (2013).

Article  CAS  PubMed  Google Scholar 

Rajapakse, S., de Silva, N. L., Weeratunga, P., Rodrigo, C. & Fernando, S. D. Prophylactic and therapeutic interventions for bleeding in dengue: a systematic review. Trans. R. Soc. Trop. Med. Hyg. 111, 433–439 (2017).

Article  CAS  PubMed  Google Scholar 

Wong, J. G., Thein, T. L., Leo, Y. S., Pang, J. & Lye, D. C. Identifying adult dengue patients at low risk for clinically significant bleeding. PLoS ONE 11, e0148579 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Capeding, M. R. et al. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial. Lancet 384, 1358–1365 (2014).

Article  CAS  PubMed  Google Scholar 

Villar, L. et al. Efficacy of a tetravalent dengue vaccine in children in Latin America. N. Engl. J. Med. 372, 113–123 (2015).

Article  PubMed  Google Scholar 

World Health, O. Dengue vaccine: WHO position paper, July 2016—recommendations. Vaccine 35, 1200–1201 (2017).

Article  Google Scholar 

Biswal, S. et al. Efficacy of a tetravalent dengue vaccine in healthy children and adolescents. N. Engl. J. Med. 381, 2009–2019 (2019).

Article  CAS  PubMed  Google Scholar 

Biswal, S. et al. Efficacy of a tetravalent dengue vaccine in healthy children aged 4-16 years: a randomised, placebo-controlled, phase 3 trial. Lancet 395, 1423–1433 (2020).

Article  CAS  PubMed  Google Scholar 

Takeda’s QDENGA (dengue tetravalent vaccine (live, attenuated)) approved in Indonesia for use regardless of prior dengue exposure. Takeda https://www.takeda.com/newsroom/newsreleases/2022/takedas-qdenga-dengue-tetravalentvaccine-live-attenuated-approved-in-indonesia-for-useregardless-of-prior-dengue-exposure/ (2022).

Thomas, S. J. & Endy, T. P. Current issues in dengue vaccination. Curr. Opin. Infect. Dis. 26, 429–434 (2013).

Article  CAS  PubMed  Google Scholar 

Low, J. G., Ooi, E. E. & Vasudevan, S. G. Current status of dengue therapeutics research and development. J. Infect. Dis. 215, S96–S102 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thomas, S. J. Is new dengue vaccine efficacy data a relief or cause for concern? NPJ Vaccines 8, 55 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Endy, T. P. et al. A phase 1, open-label assessment of a dengue virus-1 live virus human challenge strain. J. Infect. Dis. 223, 258–267 (2021).

Article  CAS  PubMed  Google Scholar 

Mammen, M. P. et al. Evaluation of dengue virus strains for human challenge studies. Vaccine 32, 1488–1494 (2014).

Article  CAS  PubMed  Google Scholar 

Sun, W. et al. Experimental dengue virus challenge of human subjects previously vaccinated with live attenuated tetravalent dengue vaccines. J. Infect. Dis. 207, 700–708 (2013).

Article  CAS  PubMed  Google Scholar 

Waickman, A. T. et al. Evolution of inflammation and immunity in a dengue virus 1 human infection model. Sci. Transl. Med. 14, eabo5019 (2022).

Article  CAS  PubMed  Google Scholar 

Waickman, A. T. et al. Transcriptional and clonal characterization of B cell plasmablast diversity following primary and secondary natural DENV infection. EBioMedicine 54, 102733 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Kirkpatrick, B. D. et al. The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model. Sci. Transl. Med. 8, 330ra336 (2016).

Article  Google Scholar 

Hou, R. et al. The innate immune response following multivalent dengue vaccination and implications for protection against dengue challenge. JCI Insight https://doi.org/10.1172/jci.insight.157811 (2022).

Nivarthi, U. K. et al. Longitudinal analysis of acute and convalescent B cell responses in a human primary dengue serotype 2 infection model. EBioMedicine 41, 465–478 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Hanley, J. P. et al. Immunotranscriptomic profiling the acute and clearance phases of a human challenge dengue virus serotype 2 infection model. Nat. Commun. 12, 3054 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sabin, A. B. Research on dengue during World War II. Am. J. Trop. Med. Hyg. 1, 30–50 (1952).

Article  CAS  PubMed  Google Scholar 

McCracken, M. K. et al. Route of inoculation and mosquito vector exposure modulate dengue virus replication kinetics and immune responses in rhesus macaques. PLoS Negl.Trop. Dis. 14, e0008191 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Dengue 3 human infection model (DENV-3). ClinicalTrials.gov https://www.clinicaltrials.gov/study/NCT04298138 (2022).

Houng, H. S., Chung-Ming Chen, R., Vaughn, D. W. & Kanesa-thasan, N. Development of a fluorogenic RT–PCR system for quantitative identification of dengue virus serotypes 1–4 using conserved and serotype-specific 3′ noncoding sequences. J. Virol. Methods 95, 19–32 (2001).

Article  CAS  PubMed  Google Scholar 

Kraus, A. A., Messer, W., Haymore, L. B. & de Silva, A. M. Comparison of plaque- and flow cytometry-based methods for measuring dengue virus neutralization. J. Clin. Microbiol. 45, 3777–3780 (2007).

Article  PubMed  PubMed Central  Google Scholar 

de Alwis, R. et al. Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions. Proc. Natl Acad. Sci. USA 109, 7439–7444 (2012).

Article  PubMed  PubMed Central  Google Scholar 

Berry, A. S. F. et al. An open-source toolkit to expand bioinformatics training in infectious diseases. mBio 12, e0121421 (2021).

Article  PubMed  Google Scholar 

Bray, N. L., Pimentel, H., Melsted, P. & Pachter, L. Erratum: near-optimal probabilistic RNA-seq quantification. Nat. Biotechnol. 34, 888 (2016).

Article  CAS  PubMed  Google Scholar 

Soneson, C., Love, M. I. & Robinson, M. D. Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences. F1000Res 4, 1521 (2015).

Article  PubMed  Google Scholar 

Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139–140 (2010).

Article  CAS  PubMed  Google Scholar 

McCarthy, D. J., Chen, Y. & Smyth, G. K. Differential expression analysis of multifactor RNA-seq experiments with respect to biological variation. Nucleic Acids Res. 40, 4288–4297 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Comments (0)

No login
gif